(Q41664462)

6 October 2017

1 reference

title

Non-insulin-dependent diabetes mellitus in the elderly (English)

1 reference

6 October 2017

Scheen AJ

1

1 reference

6 October 2017

language of work or name

1 reference

1 July 1997

1 reference

Bailliere's clinical endocrinology and metabolism

6 October 2017

published in

1 reference

6 October 2017

volume

11

1 reference

6 October 2017

issue

2

1 reference

6 October 2017

page(s)

389-406

1 reference

A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an update. European NIDDM Policy Group

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Magnesium supplementation in the treatment of diabetes. American Diabetes Association

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

The influence of aging on hemoglobin A1c (HbA1c).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

1 reference

7 January 2021

Acarbose : An Update of its Pharmacology and Therapeutic Use in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Oral antidiabetic drug use in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Benefits and Risks With Glyburide and Glipizide in Elderly NIDDM Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Deterioration of Glucose Tolerance with Age: The Role of Insulin Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Clinical evaluation of serum fructosamine in monitoring elderly outpatient diabetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Should we use intensive insulin therapy after oral agent failure in type II diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Use of premixed insulin among the elderly. Reduction of errors in patient preparation of mixtures

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Dietary management of nursing home residents with non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

The mortality of elderly people with diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

1 reference

7 January 2021

Initiation of insulin treatment after 70 years of age: patient status 2 years later.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Insulin use in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

The effectiveness of diabetes education programs for older patients and their spouses

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Effects of self-monitoring of blood glucose on quality of life in elderly diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Comparison of tolbutamide and metformin in elderly diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Glipizide pharmacokinetics: effects of age, diabetes, and multiple dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Role of metformin accumulation in metformin-associated lactic acidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Management of Non-Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Diabetes in the elderly: diagnosis, pathogenesis, and therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Diabetes in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

1 reference

7 January 2021

The Management of Diabetes Mellitus in Older Individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Diabetes mellitus in elderly patients. Is it different?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Non-insulin-dependent diabetes in older patients. Complications and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Utility of serum fructosamine as a measure of glycemia in young and old diabetic and non-diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Glucose handling, diabetes and ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Magnesium and glucose homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

A Community-based Study of Diabetes-related Skills and Knowledge in Elderly People with Insulin-requiring Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Accuracy of insulin injection in elderly patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Beneficial effect of moderate weight loss in older patients with non-insulin-dependent diabetes mellitus poorly controlled with insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

UCLA geriatric grand rounds: diabetes in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Clinical pharmacokinetics of metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Antihyperglycaemic agents. Drug interactions of clinical importance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

How to measure insulin action in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Alterations in the ultradian oscillations of insulin secretion and plasma glucose in aging

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Diabetic neuropathy in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Document of care for older people with diabetes. Special Interest Group in Diabetes, British Geriatrics Society

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Re-evaluation of a biguanide, metformin: mechanism of action and tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Physical training as treatment for type 2 (non-insulin-dependent) diabetes in elderly men. A feasibility study over 2 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Glibenclamide vs gliclazide in type 2 diabetes of the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Metformin-associated lactic acidosis in Sweden 1977-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Management of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

Comparison of different insulin regimens in elderly patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980362-X

7 January 2021

10.1016/S0950-351X(97)80362-X

Identifiers

DOI

1 reference

6 October 2017

1 reference